126 related articles for article (PubMed ID: 29305434)
21. IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer.
Fujisawa T; Joshi BH; Puri RK
Int J Cancer; 2012 Jul; 131(2):344-56. PubMed ID: 21858811
[TBL] [Abstract][Full Text] [Related]
22. Shining LIGHT on the metabolic role of the cytokine TNFSF14 and the implications on hepatic IL-6 production.
Saunders BM; Rudnicka C; Filipovska A; Davies S; Ward N; Hricova J; Schlaich MP; Matthews VB
Immunol Cell Biol; 2018 Jan; 96(1):41-53. PubMed ID: 29359470
[TBL] [Abstract][Full Text] [Related]
23. IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung.
Zheng T; Liu W; Oh SY; Zhu Z; Hu B; Homer RJ; Cohn L; Grusby MJ; Elias JA
J Immunol; 2008 Jan; 180(1):522-9. PubMed ID: 18097054
[TBL] [Abstract][Full Text] [Related]
24. IL-13 receptor alpha2 promotes epithelial cell regeneration from radiation-induced small intestinal injury in mice.
Kawashima R; Kawamura YI; Kato R; Mizutani N; Toyama-Sorimachi N; Dohi T
Gastroenterology; 2006 Jul; 131(1):130-41. PubMed ID: 16831597
[TBL] [Abstract][Full Text] [Related]
25. Allergen-dependent solubilization of IL-13 receptor alpha2 reveals a novel mechanism to regulate allergy.
Daines MO; Chen W; Tabata Y; Walker BA; Gibson AM; Masino JA; Warrier MR; Daines CL; Wenzel SE; Hershey GK
J Allergy Clin Immunol; 2007 Feb; 119(2):375-83. PubMed ID: 17140645
[TBL] [Abstract][Full Text] [Related]
26. Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in Obesity.
Ham M; Choe SS; Shin KC; Choi G; Kim JW; Noh JR; Kim YH; Ryu JW; Yoon KH; Lee CH; Kim JB
Diabetes; 2016 Sep; 65(9):2624-38. PubMed ID: 27284106
[TBL] [Abstract][Full Text] [Related]
27. Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease.
Karmele EP; Pasricha TS; Ramalingam TR; Thompson RW; Gieseck RL; Knilans KJ; Hegen M; Farmer M; Jin F; Kleinman A; Hinds DA; ; Almeida Pereira T; de Queiroz Prado R; Bing N; Tchistiakova L; Kasaian MT; Wynn TA; Vannella KM
Mucosal Immunol; 2019 Sep; 12(5):1174-1186. PubMed ID: 31308480
[TBL] [Abstract][Full Text] [Related]
28. IL-33-driven ILC2/eosinophil axis in fat is induced by sympathetic tone and suppressed by obesity.
Ding X; Luo Y; Zhang X; Zheng H; Yang X; Yang X; Liu M
J Endocrinol; 2016 Oct; 231(1):35-48. PubMed ID: 27562191
[TBL] [Abstract][Full Text] [Related]
29. Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy.
Knudson KM; Hwang S; McCann MS; Joshi BH; Husain SR; Puri RK
Front Immunol; 2022; 13():878365. PubMed ID: 35464460
[TBL] [Abstract][Full Text] [Related]
30. CTRP7 deletion attenuates obesity-linked glucose intolerance, adipose tissue inflammation, and hepatic stress.
Petersen PS; Lei X; Wolf RM; Rodriguez S; Tan SY; Little HC; Schweitzer MA; Magnuson TH; Steele KE; Wong GW
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E309-E325. PubMed ID: 28223291
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association.
Pham TH; Bak Y; Oh JW; Hong J; Lee S; Hong JT; Yoon DY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010051
[TBL] [Abstract][Full Text] [Related]
32. Macrophage infiltration into obese adipose tissues suppresses the induction of UCP1 level in mice.
Sakamoto T; Nitta T; Maruno K; Yeh YS; Kuwata H; Tomita K; Goto T; Takahashi N; Kawada T
Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E676-E687. PubMed ID: 26884382
[TBL] [Abstract][Full Text] [Related]
33. IL-13 receptor isoforms: breaking through the complexity.
Tabata Y; Khurana Hershey GK
Curr Allergy Asthma Rep; 2007 Sep; 7(5):338-45. PubMed ID: 17697639
[TBL] [Abstract][Full Text] [Related]
34. CCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue.
Bolus WR; Gutierrez DA; Kennedy AJ; Anderson-Baucum EK; Hasty AH
J Leukoc Biol; 2015 Oct; 98(4):467-77. PubMed ID: 25934927
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts.
Takenouchi M; Hirai S; Sakuragi N; Yagita H; Hamada H; Kato K
Clin Cancer Res; 2011 May; 17(9):2819-29. PubMed ID: 21357681
[TBL] [Abstract][Full Text] [Related]
36. The fractalkine/Cx3CR1 system is implicated in the development of metabolic visceral adipose tissue inflammation in obesity.
Polyák A; Ferenczi S; Dénes A; Winkler Z; Kriszt R; Pintér-Kübler B; Kovács KJ
Brain Behav Immun; 2014 May; 38():25-35. PubMed ID: 24456845
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2.
Lupardus PJ; Birnbaum ME; Garcia KC
Structure; 2010 Mar; 18(3):332-42. PubMed ID: 20223216
[TBL] [Abstract][Full Text] [Related]
38. The innate antiviral response upregulates IL-13 receptor α2 in bronchial fibroblasts.
Campbell-Harding G; Sawkins H; Bedke N; Holgate ST; Davies DE; Andrews AL
J Allergy Clin Immunol; 2013 Mar; 131(3):849-55. PubMed ID: 23069489
[TBL] [Abstract][Full Text] [Related]
39. Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice.
Moya-Pérez A; Neef A; Sanz Y
PLoS One; 2015; 10(7):e0126976. PubMed ID: 26161548
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation.
Martínez-Martínez E; Cachofeiro V; Rousseau E; Álvarez V; Calvier L; Fernández-Celis A; Leroy C; Miana M; Jurado-López R; Briones AM; Jaisser F; Zannad F; Rossignol P; López-Andrés N
Mol Cell Endocrinol; 2015 Aug; 411():20-7. PubMed ID: 25896545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
